CCND1 and cancer: High percentages of precancerous and cancer cells exhibit increased cyclin D1, antigen identified by monoclonal antibody (Ki67), proliferating cell nuclear antigen (PCNA), phosphorylated ERK1/2 and phosphorylated STAT5 [31–33,35].